Therefore, we used CD4+CD25+CD127low/− cells as the immunophenotype of Tregs and found that the frequencies of CD4+CD25+CD127low/− Tregs in BM and PB were increased in AML patients. Here, CD4 is linked to acute myeloid leukemia.